Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold — Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
Business Insider2d
Monte Rosa Therapeutics Expands Pipeline with Novartis Deal
In its latest financial report, Monte Rosa Therapeutics has announced a significant partnership with Novartis, alongside progress in its pipeline of drug candidates. The partnership involves a global ...
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
RYTELOâ„¢ (imetelstat) is FDA approved for the treatment of low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent ...
pharmaphorum4d
Welcome to the Molecular Glue Drug Development Summit!
The Molecular Glue Drug Development Summit returns to Boston with fresh insights and opportunities! With powerhouse ...
BioSpace6d
Lacks Family Lawsuits Seek Share of Profits Stemming from HeLa Cells
A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using ...
Non-Hodgkin’s Lymphoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...